Evaluation of The Effect of Music Therapy on Dyspnea Severity and Vital Signs In Intensive Care Patients

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to investigate the effect of music therapy on dyspnea severity and quality of life indicators in patients with Chronic Obstructive Pulmonary Disease (COPD) admitted to the intensive care unit. The study will be conducted at Isparta City Hospital and Kumluca State Hospital in Antalya, Turkey, using an experimental design. Patients will be divided into experimental and control groups, selected using randomization. Patients in the experimental group will receive music therapy in the Hüseyni maqam, while those in the control group will not receive any music therapy. Life indicators and Modified Borg Scale (MBS) values of patients in the experimental group will be recorded before, immediately after, and 30 minutes post-application. Music therapy will be administered to patients for only one day, once in the morning. Data for patients in the control group will be collected at the same time intervals. The results of this study aim to contribute to the literature on the impact of music therapy on dyspnea severity and quality of life indicators in COPD patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Being treated as a patient in intensive care.

• Being monitored with a diagnosis of COPD (Chronic Obstructive Pulmonary Disease).

• Currently undergoing treatment for dyspnea symptoms.

• Volunteering to participate in the research.

• Receiving treatment at Kumluca State Hospital.

• Receiving treatment at Isparta City Hospital.

• Being 18 years of age or older.

• Having intact consciousness and full capacity for judgment.

• Being able to read and write.

• Speaking Turkish.

• Having no communication barriers.

Locations
Other Locations
Turkey
Suleyman Demırel University
RECRUITING
Isparta
Contact Information
Primary
Hafize Aydemir
aydemirhafize1998@gmail.com
+905078380979
Backup
Kamuran Cerit
kamurancerit@gmail.com
+905336199839
Time Frame
Start Date: 2024-01-07
Estimated Completion Date: 2024-06-30
Participants
Target number of participants: 60
Treatments
Experimental: Music Therapy
The Patient Identification Form, Modified Borg Scale, Vital Signs Record Chart, and Blood Test Results Record Chart will be completed when the patient is first admitted to the ward. Music therapy intervention will be administered between 6:00 AM and 12:00 PM. Before the music therapy session, the patient will lie on their back at a 30-45 degree angle and rest for 5 minutes. The Modified Borg Scale and Vital Signs Record Chart will be completed just before the music therapy session begins. During the session, the patient will receive the music therapy intervention through headphones for 30 minutes. At the end of the 30-minute music session, the Modified Borg Scale and Vital Signs Record Chart will be completed again. Thirty minutes after the end of the music therapy intervention, the Modified Borg Scale and Vital Signs Record Chart will be completed once more.
Other: No Music Therapy
When the patient is admitted to the ward, the Patient Identification Form, Modified Borg Scale, Vital Signs Record Chart, and Blood Test Results Record Chart will be completed. Music therapy will not be applied to this group; however, patients will be provided with headphones to maintain consistent conditions. When the patient is ready, between 6:00 AM and 12:00 PM, they will lie on their back at a 30-45 degree angle and rest for 5 minutes. The Modified Borg Scale and Vital Signs Record Chart will be completed just before the patient puts on the headphones. Once the session begins, the patient will quietly spend 30 minutes with headphones. After 30 minutes, the Modified Borg Scale and Vital Signs Record Chart will be filled out again. Thirty minutes after the end of the session, the Modified Borg Scale and Vital Signs Record Chart will be completed again.
Sponsors
Leads: Suleyman Demirel University

This content was sourced from clinicaltrials.gov